Does docetaxel plus prednisone prolong the survival of men with metastatic hormone-refractory prostate cancer?

Related Experiment Video

Updated: Aug 15, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Andrew Protheroe1

  • 1Cancer Research UK, Department of Medical Oncology, Churchill Hospital, Oxford. Kay.Castle@cancer.org.uk

Nature Clinical Practice. Oncology
|November 3, 2005
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos